BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21525011)

  • 1. Involvement of Jun dimerization protein 2 (JDP2) in the maintenance of Epstein-Barr virus latency.
    Murata T; Noda C; Saito S; Kawashima D; Sugimoto A; Isomura H; Kanda T; Yokoyama KK; Tsurumi T
    J Biol Chem; 2011 Jun; 286(25):22007-16. PubMed ID: 21525011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TORC2, a coactivator of cAMP-response element-binding protein, promotes Epstein-Barr virus reactivation from latency through interaction with viral BZLF1 protein.
    Murata T; Sato Y; Nakayama S; Kudoh A; Iwahori S; Isomura H; Tajima M; Hishiki T; Ohshima T; Hijikata M; Shimotohno K; Tsurumi T
    J Biol Chem; 2009 Mar; 284(12):8033-41. PubMed ID: 19164291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ZIIR element of the Epstein-Barr virus BZLF1 promoter plays a central role in establishment and maintenance of viral latency.
    Yu X; McCarthy PJ; Lim HJ; Iempridee T; Kraus RJ; Gorlen DA; Mertz JE
    J Virol; 2011 May; 85(10):5081-90. PubMed ID: 21389123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells.
    Murata T; Kondo Y; Sugimoto A; Kawashima D; Saito S; Isomura H; Kanda T; Tsurumi T
    J Virol; 2012 May; 86(9):4752-61. PubMed ID: 22357272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Epstein-Barr virus reactivation from latency.
    Murata T
    Microbiol Immunol; 2014 Jun; 58(6):307-17. PubMed ID: 24786491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a negative cis element within the ZII domain of the Epstein-Barr virus lytic switch BZLF1 gene promoter.
    Liu P; Liu S; Speck SH
    J Virol; 1998 Oct; 72(10):8230-9. PubMed ID: 9733866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus type 1 infection activates the Epstein-Barr virus replicative cycle via a CREB-dependent mechanism.
    Wu H; Li T; Zeng M; Peng T
    Cell Microbiol; 2012 Apr; 14(4):546-59. PubMed ID: 22188237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of myocyte enhancer factor 2 family transcription factors to BZLF1 expression in Epstein-Barr virus reactivation from latency.
    Murata T; Narita Y; Sugimoto A; Kawashima D; Kanda T; Tsurumi T
    J Virol; 2013 Sep; 87(18):10148-62. PubMed ID: 23843637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of ZIIBC, a complex formed by cellular factors and the ZII site of the Epstein-Barr virus BZLF1 promoter.
    Ruf IK; Rawlins DR
    J Virol; 1995 Dec; 69(12):7648-57. PubMed ID: 7494273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definition of the transcription factors which bind the differentiation responsive element of the Epstein-Barr virus BZLF1 Z promoter in human epithelial cells.
    MacCallum P; Karimi L; Nicholson LJ
    J Gen Virol; 1999 Jun; 80 ( Pt 6)():1501-1512. PubMed ID: 10374969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner.
    Ellis AL; Wang Z; Yu X; Mertz JE
    J Virol; 2010 Jun; 84(12):6139-52. PubMed ID: 20375168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of ARKL1 as a Negative Regulator of Epstein-Barr Virus Reactivation.
    Siddiqi UZ; Vaidya AS; Li X; Marcon E; Tsao SW; Greenblatt J; Frappier L
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31341047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.
    Kraus RJ; Mirocha SJ; Stephany HM; Puchalski JR; Mertz JE
    J Virol; 2001 Jan; 75(2):867-77. PubMed ID: 11134300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1.
    Robinson AR; Kwek SS; Kenney SC
    PLoS Pathog; 2012 Feb; 8(2):e1002516. PubMed ID: 22346751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching of EBV cycles between latent and lytic states.
    Murata T; Tsurumi T
    Rev Med Virol; 2014 May; 24(3):142-53. PubMed ID: 24339346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter.
    Sun CC; Thorley-Lawson DA
    J Virol; 2007 Dec; 81(24):13566-77. PubMed ID: 17898050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin-treated B cells.
    Daibata M; Speck SH; Mulder C; Sairenji T
    Virology; 1994 Feb; 198(2):446-54. PubMed ID: 8291228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.
    Reusch JA; Nawandar DM; Wright KL; Kenney SC; Mertz JE
    J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors.
    Countryman JK; Gradoville L; Miller G
    J Virol; 2008 May; 82(10):4706-19. PubMed ID: 18337569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta-induced reactivation of Epstein-Barr virus involves multiple Smad-binding elements cooperatively activating expression of the latent-lytic switch BZLF1 gene.
    Iempridee T; Das S; Xu I; Mertz JE
    J Virol; 2011 Aug; 85(15):7836-48. PubMed ID: 21593157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.